Company · CIK 0001693415 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Translate Bio, Inc. · TBIO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2018 PForm 4 → | Jul 5, 4:30 pm EDT | Brian M. Gallagher Jr.Director | 269,230 | $13.00 | $3,499,990 | 3,697,912 | +7.85% | plan? |
| Jul 2, 2018 CForm 4 → | Jul 5, 4:30 pm EDT | Brian M. Gallagher Jr.Director | 3,428,682 | — | — | 3,428,682 | — | plan? |
| Jul 2, 2018 CForm 4 → | Jul 3, 8:17 pm EDT | Ronald C Renaud Jr.See Remarks, Director | 81,818 | — | — | 40,909 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 3, 6:44 pm EDT | MRL Ventures Fund LLC10% Owner | 25,000 | $13.00 | $325,000 | 1,873,503 | +1.35% | plan? |
| Jul 2, 2018 CForm 4 → | Jul 3, 6:44 pm EDT | MRL Ventures Fund LLC10% Owner | 1,848,503 | — | — | 1,848,503 | — | plan? |
| Jul 2, 2018 CForm 4 → | Jul 3, 6:44 pm EDT | Omega Fund IV, L.P. +910% Owner | 4,875,206 | — | — | 1,458,424 | — | plan? |
| Jul 2, 2018 CForm 4 → | Jul 3, 6:43 pm EDT | Atlas Venture Fund VIII, L.P. +210% Owner | 3,832,010 | — | — | 3,922,010 | — | plan? |
| Jul 2, 2018 CForm 4 → | Jul 3, 6:37 pm EDT | Jean Francois FormelaDirector | 3,832,010 | — | — | 3,922,010 | — | plan? |
| Jul 2, 2018 PForm 4 → | Jul 3, 5:59 pm EDT | GLAXOSMITHKLINE PLC10% Owner | 269,230 | $13.00 | $3,499,990 | 3,697,912 | +7.85% | plan? |
| Jul 2, 2018 CForm 4 → | Jul 3, 5:59 pm EDT | GLAXOSMITHKLINE PLC10% Owner | 3,428,682 | — | — | 3,428,682 | — | plan? |
| Jul 2, 2018 JForm 4 → | Jul 2, 9:46 pm EDT | Shire Human Genetic Therapies, Inc. +110% Owner | 183,619 | — | — | 7,078,945 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2019 AForm 4 → | Mar 12, 6:14 pm EDT | John R. SchroerChief Financial Officer | 125,000 | — | — | 125,000 | — | |
| Mar 8, 2019 AForm 4 → | Mar 12, 6:14 pm EDT | Ronald C Renaud Jr.Chief Executive Officer, Director | 500,000 | — | — | 500,000 | — | |
| Mar 8, 2019 AForm 4 → | Mar 12, 6:13 pm EDT | Michael HeartleinChief Scientific Officer | 150,000 | — | — | 150,000 | — | |
| Mar 8, 2019 AForm 4 → | Mar 12, 6:12 pm EDT | Brian FentonChief Business Officer | 90,000 | — | — | 90,000 | — | |
| Mar 8, 2019 AForm 4 → | Mar 12, 6:11 pm EDT | Paula CloghessyChief Human Resources Officer | 60,000 | — | — | 60,000 | — | |
| Mar 8, 2019 AForm 4 → | Mar 12, 6:10 pm EDT | Paul D. BurgessChief Legal Officer | 150,000 | — | — | 150,000 | — | |
| Mar 8, 2019 AForm 4 → | Mar 12, 6:09 pm EDT | Ann BarbierChief Medical Officer | 125,000 | — | — | 125,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 3, 5:20 pm EST | Robert J. MeyerDirector | 37,800 | — | — | 37,800 | — | |
| Jul 2, 2018 CForm 4 → | Jul 5, 4:30 pm EDT | Brian M. Gallagher Jr.Director | 19,048,050 | — | — | 0 | — | |
| Jul 2, 2018 CForm 4 → | Jul 3, 8:17 pm EDT | Ronald C Renaud Jr.See Remarks, Director | 454,544 | — | — | 0 | — | |
| Jul 2, 2018 CForm 4 → | Jul 3, 6:44 pm EDT | MRL Ventures Fund LLC10% Owner | 10,269,360 | — | — | 0 | — | |
| Jul 2, 2018 CForm 4 → | Jul 3, 6:44 pm EDT | Omega Fund IV, L.P. +910% Owner | 27,084,216 | — | — | 0 | — | |
| Jul 2, 2018 CForm 4 → | Jul 3, 6:43 pm EDT | Atlas Venture Fund VIII, L.P. +210% Owner | 21,288,727 | — | — | 0 | — | |
| Jul 2, 2018 CForm 4 → | Jul 3, 6:37 pm EDT | Jean Francois FormelaDirector | 21,288,727 | — | — | 0 | — | |
| Jul 2, 2018 CForm 4 → | Jul 3, 5:59 pm EDT | GLAXOSMITHKLINE PLC10% Owner | 19,048,050 | — | — | 0 | — |